Vertex angers U.K. cystic fibrosis patients with delay on new drug data

Vertex angers U.K. cystic fibrosis patients with delay on new drug data

STAT Plus: Vertex angers U.K. cystic fibrosis patients with a delay in submitting data for its newest therapy

By ED SILVERMAN

BILL SIKES/AP

Vertex has sparked anger among cystic fibrosis patients by requesting extra time to submit evidence for a new therapy to a U.K. cost-effectiveness agency

READ MORE